The Journal of Translational Health & Precision Medicine is an international, peer-reviewed scholarly journal dedicated to advancing high-quality research that bridges discovery science, clinical practice, and population health. The journal provides a multidisciplinary platform for studies that demonstrate clear translational pathways from experimental, clinical, and population-level evidence to real-world health impact.

The journal publishes rigorously reviewed original research, systematic reviews, clinical and translational studies, methodological papers, and policy-relevant contributions across the fields of translational and precision medicine, clinical research, digital health, artificial intelligence in healthcare, molecular diagnostics, population health, and health systems research. Submissions involving preclinical, experimental, computational, or in silico approaches are considered when authors clearly articulate their translational relevance and potential implications for human health.

A defining feature of the journal is its mandatory Translational Relevance Statement, which ensures that all published work contributes meaningfully to clinical practice, diagnostics, public health, policy, or implementation science. The journal emphasizes scientific rigor, ethical integrity, transparency, and editorial independence, and operates under a double-blind peer-review process with verified reviewers.

The Journal of Translational Health & Precision Medicine is committed to international standards of research ethics and publication integrity, aligning with the principles and guidelines of the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the World Medical Association (WMA). The journal supports open science practices and aims to enhance global visibility, impact, and trust in translational health research.

  • Publisher: Open Meridian Press LLC (Delaware, USA)
  • Publication frequency: Quarterly
  • Launch: Volume 1, Issue 1 — May 2026
  • Peer review: Double-blind
  • Open access license: Open Access under CC BY 4.0
  • Fees: $0 (no submission or publication fees)
  • ISSN (Online): Pending
  • DOIs: Planned starting Volume 1, Issue 1